Takeshima N - Search Results

1

Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer.

Takehara K, Matsumoto T, Hamanishi J, Hasegawa K, Matsuura M, Miura K, Nagao S, Nakai H, Tanaka N, Tokunaga H, Ushijima K, Watari H, Yokoyama Y, Kase Y, Sumino S, Suri A, Itamochi H, Takeshima N. Takehara K, et al. Among authors: takeshima n. J Gynecol Oncol. 2021 Mar;32(2):e21. doi: 10.3802/jgo.2021.32.e21. Epub 2021 Jan 6. J Gynecol Oncol. 2021. PMID: 33470063 Free PMC article. Clinical Trial.

2

Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma.

Takeshima N, Shimizu Y, Umezawa S, Hirai Y, Chen JT, Fujimoto I, Yamauchi K, Hasumi K. Takeshima N, et al. Gynecol Oncol. 1994 Sep;54(3):321-6. doi: 10.1006/gyno.1994.1217. Gynecol Oncol. 1994. PMID: 8088608

3

Ovarian hemangioma associated with concomitant stromal luteinization and ascites.

Yamawaki T, Hirai Y, Takeshima N, Hasumi K. Yamawaki T, et al. Among authors: takeshima n. Gynecol Oncol. 1996 Jun;61(3):438-41. doi: 10.1006/gyno.1996.0170. Gynecol Oncol. 1996. PMID: 8641629 Review.

4

Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion.

Takeshima N, Hirai Y, Tanaka N, Yamawaki T, Yamauchi K, Hasumi K. Takeshima N, et al. Obstet Gynecol. 1996 Aug;88(2):280-2. doi: 10.1016/0029-7844(96)00115-9. Obstet Gynecol. 1996. PMID: 8692516

5

Ovarian metastasis in endometrial carcinoma.

Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K. Takeshima N, et al. Gynecol Oncol. 1998 Aug;70(2):183-7. doi: 10.1006/gyno.1998.5086. Gynecol Oncol. 1998. PMID: 9740687

6

Low-grade endometrial stromal sarcoma with cardiovascular involvement--a report of three cases.

Tabata T, Takeshima N, Hirai Y, Hasumi K. Tabata T, et al. Among authors: takeshima n. Gynecol Oncol. 1999 Dec;75(3):495-8. doi: 10.1006/gyno.1999.5598. Gynecol Oncol. 1999. PMID: 10600315

7

Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas.

Suehiro Y, Sakamoto M, Umayahara K, Iwabuchi H, Sakamoto H, Tanaka N, Takeshima N, Yamauchi K, Hasumi K, Akiya T, Sakunaga H, Muroya T, Numa F, Kato H, Tenjin Y, Sugishita T. Suehiro Y, et al. Among authors: takeshima n. Oncology. 2000 Jun;59(1):50-6. doi: 10.1159/000012137. Oncology. 2000. PMID: 10895067

8

Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.

Tabata T, Takeshima N, Tanaka N, Hirai Y, Hasumi K. Tabata T, et al. Among authors: takeshima n. Tumour Biol. 2000 Nov-Dec;21(6):375-80. doi: 10.1159/000030143. Tumour Biol. 2000. PMID: 11006578

9

CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma.

Tate S, Hirai Y, Takeshima N, Hasumi K. Tate S, et al. Among authors: takeshima n. Gynecol Oncol. 2005 Jan;96(1):143-9. doi: 10.1016/j.ygyno.2004.09.020. Gynecol Oncol. 2005. PMID: 15589593

10

Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy.

Matsumura M, Takeshima N, Ota T, Omatsu K, Sakamoto K, Kawamata Y, Umayahara K, Tanaka H, Akiyama F, Takizawa K. Matsumura M, et al. Among authors: takeshima n. Gynecol Oncol. 2010 Nov;119(2):212-6. doi: 10.1016/j.ygyno.2010.07.031. Epub 2010 Aug 14. Gynecol Oncol. 2010. PMID: 20709382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters